Idera Pharmaceuticals Inc (IDRA.OQ) Analyst Research| Reuters.com
Edition:
United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

1.48USD
24 Jun 2016
Change (% chg)

$-0.05 (-3.27%)
Prev Close
$1.53
Open
$1.44
Day's High
$1.50
Day's Low
$1.42
Volume
525,504
Avg. Vol
137,813
52-wk High
$4.42
52-wk Low
$1.20

Reports per page
Select Report Title Date Provider Pgs Price
Idera Pharmaceuticals 5:29am EDT S&P Capital IQ Quantitative Report 9 104.00
Idera Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - Idera Pharmaceuticals Inc (IDRA-O) 24 Jun 2016 Thomson Reuters Stock Report 12 25.00
IDRA: Due Diligence Review: Forensic Earnings and Valuation 23 Jun 2016 New Constructs, LLC 10 25.00
Value Graph: IDERA PHARMACEUT -- IDRA 23 Jun 2016 Ford Investor Services, Inc. 1 12.00
Trading Report for (IDRA). A detailed report, including free correlated market analysis, and updates. 18 Jun 2016 Stock Traders Daily 6 20.00
ValuEngine Rating and Forecast Report for IDRA 18 Jun 2016 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Idera Pharmaceuticals, Inc. 31 May 2016 Wright Reports 61 75.00
Thomson Reuters Stock Report - Idera Pharmaceuticals Inc (IDRA-O) 10 May 2016 Thomson Reuters Stock Report 12 25.00
Idera Pharmaceuticals, Inc. (IDRA) - Financial and Strategic SWOT Analysis Review 10 May 2016 GlobalData 65 300.00
 
Name Age Since Current Position

James Geraghty

60 2013 Independent Chairman of the Board

Vincent Milano

51 2014 President, Chief Executive Officer, Director

Youssef El Zein

66 1997 Independent Vice Chairman of the Board

Louis Arcudi

54 2011 Chief Financial Officer, Senior Vice President - Operations, Treasurer, Secretary

Robert Fletcher

52 2015 Senior Vice President - Business Development and Strategic Planning